Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1;35(12):1774-1777.
doi: 10.1681/ASN.0000000532. Epub 2024 Sep 27.

Treating the Untreatable: Antisense Oligonucleotides as an Individualized Therapy for Rare Genetic Kidney Diseases

Cedrik Tekendo-Ngongang  1 , Joseph G Gleeson  1   2   3 , Laurence Mignon  1
Affiliations

Treating the Untreatable: Antisense Oligonucleotides as an Individualized Therapy for Rare Genetic Kidney Diseases

Cedrik Tekendo-Ngongang et al. J Am Soc Nephrol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure forms, as provided by each author, are available with the online version of the article at http://links.lww.com/JSN/E871.

Similar articles

See all similar articles

References

    1. Crooke ST, Baker BF, Crooke RM, Liang Xhai. Antisense technology: an overview and prospectus. Nat Rev Drug Discov. 2021;20(6):427–453. doi:10.1038/s41573-021-00162-z - DOI - PubMed
    1. Gleeson JG Bennett CF Carroll JB, et al. . Personalized antisense oligonucleotides ‘for free, for life’—the n-Lorem Foundation. Nat Med. 2023;29(6):1302–1303. doi:10.1038/s41591-023-02335-2 - DOI - PubMed
    1. Crooke ST, Liang Xhai, Crooke RM, Baker BF, Geary RS. Antisense drug discovery and development technology considered in a pharmacological context. Biochem Pharmacol. 2021;189:114196. doi:10.1016/j.bcp.2020.114196 - DOI - PubMed
    1. Engelhardt JA. Comparative renal toxicopathology of antisense oligonucleotides. Nucleic Acid Ther. 2016;26(4):199–209. doi:10.1089/nat.2015.0598 - DOI - PubMed
    1. Donner AJ, Bell TA, Greenlee S, Graham MJ, Crooke RM. Characterization of the activity and distribution of a 2′-O-Methoxyethyl-Modified antisense oligonucleotide in models of acute and chronic kidney disease. Nucleic Acid Ther. 2018;28(5):297–306. doi:10.1089/nat.2018.0723 - DOI - PubMed

Associated data

LinkOut - more resources